Clinical Trial Update: Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial TRIBECA is evaluating belimumab versus placebo for non-infectious cryoglobulinemic vasculitis, assessing efficacy and safety. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryoglobulinemic Vasculitis
• Vasculitis

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Vasculitis, Cryoglobulinemia | Phase 2 | Status: RECRUITING